BCL2 proteins are crucial components of the mitochondrial apoptotic response, and high expression is seen in AML cells; BCL2 inhibition via VEN (VEN) has been shown to improve outcomes in elderly patients with AML when combined with hypomethylating agents (HMAs) [8]. Here, BCL2 is linked to acute myeloid leukemia.